{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:52:35Z","timestamp":1781675555588,"version":"3.54.5"},"reference-count":17,"publisher":"Norwegian Medical Association","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2009,8,27]]},"DOI":"10.4045\/tidsskr.09.33690","type":"journal-article","created":{"date-parts":[[2009,8,31]],"date-time":"2009-08-31T09:56:18Z","timestamp":1251712578000},"page":"1639-42","source":"Crossref","is-referenced-by-count":4,"title":["Korttids hepatitt C-behandling av heroinavhengige pasienter"],"prefix":"10.4045","volume":"129","author":[{"given":"\u00d8istein","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sund\u00f8y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Skeie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-K\u00e5re","family":"Vederhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingebj\u00f8rg","family":"\u00d8ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Opsal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Rysstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frode","family":"Gallefoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","unstructured":"Bell H, Dalgard O, Bj\u00f8ro K et al. Behandling ved kronisk hepatitt C. Tidsskr Nor L\u00e6geforen 2002; 122: 926-8."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2005; 345: 41\u2009\u2013\u200952.","DOI":"10.1056\/NEJM200107053450107"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Deuffic-Burban S, Wong JB, Valleron AJ et al. Comparing the public health burden of chronic hepatitis C and HIV infection in France. J Hepatol 2004; 40: 319\u2009\u2013\u200926.","DOI":"10.1016\/j.jhep.2003.10.018"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Dalgard O, Jeansson S, Skaug K et al. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol 2003; 38: 864\u2009\u2013\u200970.","DOI":"10.1016\/S0168-8278(03)80729-8"},{"key":"ref=5","unstructured":"Kristensen O, Espegren O, Asland R et al. Buprenorfin og metadon til opiatavhengige - en randomisert studie. Tidsskr Nor L\u00e6geforen 2005; 125: 148-51."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Dalgard O, Egeland A, Ervik R et al. Risikofaktorer for hepatitt C-smitte blant spr\u00f8ytenarkomane. Tidsskr Nor Legeforen 2009; 129: 101-4.","DOI":"10.4045\/tidsskr.09.35002"},{"key":"ref=7","unstructured":"NIH Consensus Development Program. Management of Hepatitis C. http:\/\/consensus.nih.gov\/2002\/2002HepatitisC2002116html.htm, (30.3.2009)."},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Dalgard O, Bjoro K, Hellum KB et al. Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. Hepatology 2004; 40: 1260\u2009\u2013\u20095.","DOI":"10.1002\/hep.20467"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Ide T, Kumashiro R, Hino T et al. Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels. Hepatol Res 2002; 22: 145\u2009\u2013\u200951.","DOI":"10.1016\/S1386-6346(01)00127-9"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Nomura H, Tsuchiya Y, Maruyama T et al. The effects of a high dose, short course of interferon on hepatitis C. J Gastroenterol Hepatol 1999; 14: 85\u2009\u2013\u20099.","DOI":"10.1046\/j.1440-1746.1999.01801.x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Lagging M, Langeland N, Pedersen et al. Randomized comparison of 12 or 24 weeks of peginterferon \u03b1-2a and ribavirin in chronic hepatitis C virus genotype 2\/3 infection. Hepatology 2008; 47: 1837\u2009\u2013\u200945.","DOI":"10.1002\/hep.22253"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Shiffman ML, Suter F, Bacon BR et al. Peginterferon alfa-2a and ribavivirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl\u00a0J Med 2007; 357: 124\u2009\u2013\u200934.","DOI":"10.1056\/NEJMoa066403"},{"key":"ref=13","unstructured":"Vik ISS, Skaug K, Dalgard O et al. Hepatitt C - et helseproblem ogs\u00e5 i Norge. Tidsskr Nor Legeforen 2008; 128: 563-6."},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Svanborg P, Asberg M. A comparison between the\u00a0Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord 2001; 64: 203\u2009\u2013\u200916.","DOI":"10.1016\/S0165-0327(00)00242-1"},{"key":"ref=15","unstructured":"Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale, preliminary report. Psychol Bull 1973; 9: 13\u2009\u2013\u200928."},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Mauss S, Berger F, Goelz J et al. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology 2004; 40: 120\u2009\u2013\u20094.","DOI":"10.1002\/hep.20279"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Krook AL, Stokka D, Heger B et al. Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study. Eur Addict Res 2007; 13: 216\u2009\u2013\u200921.","DOI":"10.1159\/000104884"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:03:00Z","timestamp":1781672580000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2009\/08\/aktuelt\/korttids-hepatitt-c-behandling-av-heroinavhengige-pasienter"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,27]]},"references-count":17,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2009,8,27]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.33690","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,27]]}}}